Suppressive effects of bilobalide on depression-like behaviors induced by chronic unpredictable mild stress in mice
- 10 August 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 14 (18) , 8409-8419
Abstract
Background: Depression is a psychiatric disorder with depressed mood and even suicide attempts as the main clinical symptoms, and its pathogenesis has not yet been fully elucidated. Brain derived neurotrophic factor (BDNF) plays an important role in the pathogenesis of depression. Purpose: The main aim of the present study was to evaluate the effectiveness and reveal the potential mechanisms of bilobalide (BB) intervention in alleviating depression-like behaviors by using chronic unpredictable mild stress (CUMS) mice via mediating the BDNF pathway. Methods: Behavioral assessments were carried out by using the sucrose preference test (SPT), tail suspension test (TST), and forced swimming test (FST). CUMS mice were randomly divided into 5 groups: CUMS + solvent, CUMS + BB low, CUMS + BB medium, CUMS + BB high and CUMS + fluoxetine. Total serum levels of tumor necrosis factor (TNF-α) and interleukin-6 (IL-6) were measured by ELISA. Expression of TNF-α, IL-6, AKT, GSK3β, β-catenin, Trk-B and BDNF in the mouse hippocampus was assessed by western blotting. Results: BB treatment reduced the levels of pro-inflammatory cytokines (IL-6 and TNF-α) and increased the protein expression of BDNF in the hippocampus region of the CUMS mice. Moreover, BB treatment enhanced the AKT/GSK3β/β-catenin signaling pathway which is downstream of the BDNF receptor Trk-B in the hippocampus of these mice. Conclusions: Overall, the experimental results indicated that BB reverses CUMS-induced depression-like behavior. BB exerts antidepressant-like effects by inhibiting neuroinflammation and enhancing the function of neurotrophic factors.Keywords
Funding Information
- Natural Science Foundation of Anhui Province (No. 1808085MC77)
- Fundamental Research Funds for the Central Universities (No. PA2022GDGP0031)
This publication has 51 references indexed in Scilit:
- Iptakalim confers an antidepressant effect in a chronic mild stress model of depression through regulating neuro-inflammation and neurogenesisInternational Journal of Neuropsychopharmacology, 2014
- Overview of Botanical Status in EU, USA, and ThailandEvidence-Based Complementary and Alternative Medicine, 2013
- Glucocorticoid-Related Molecular Signaling Pathways Regulating Hippocampal NeurogenesisNeuropsychopharmacology, 2012
- Effects of bilobalide on anxiety, spatial learning, memory and levels of hippocampal glucocorticoid receptors in male Kunming micePhytomedicine, 2012
- The Tail Suspension TestJournal of Visualized Experiments, 2011
- The effects of chronic glucocorticoid exposure on dendritic length, synapse numbers and glial volume in animal models: Implications for hippocampal volume reductions in depressionPhysiology & Behavior, 2010
- Bilobalide modulates serotonin-controlled behaviors in the nematode Caenorhabditis elegansBMC Neuroscience, 2009
- Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticalsJournal of Chromatography A, 2009
- Novel Drugs and Therapeutic Targets for Severe Mood DisordersNeuropsychopharmacology, 2008
- Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatmentPsychopharmacology, 2005